4//SEC Filing
DelMar Pharmaceuticals, Inc. 4
Accession 0001213900-17-004749
$HURACIK 0001498382operating
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:58 PM ET
Size
4.5 KB
Accession
0001213900-17-004749
Insider Transaction Report
Form 4
BACHA JEFFREY
CEO and President10% Owner
Transactions
- Purchase
Common Stock
2017-05-05$2.20/sh+2,500$5,500→ 41,645 total
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001498382
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:58 PM ET
- Size
- 4.5 KB